| Generation of nanobodies against immunomodulating checkpoint receptors in glioblastoma tumor cells |
|
|
|
Prof. dr. Robert Roškar |
|
CELSA |
|
1.10.2020 - 30.9.2022 |
| The role of snoRNAs in the etiology of inflammatory bowel disease |
|
|
|
Izr. prof. dr. Tomaž Bratkovič |
|
CELSA |
|
1.10.2022 - 30.9.2024 |
| Razvoj raziskovalne infrastrukture za mednarodno konkurenčnost slovenskega RRI prostora |
|
|
|
Prof. dr. Irena Mlinarič-Raščan |
|
EATRIS ERIC |
|
2021 - 2030 |
| Digital Osce for Medical specialities - INnOvatlon for Students |
|
DOMINOS |
|
Prof. dr. Mitja Kos |
|
ERASMUS+ |
|
1.1.2022 - 31.12.2024 |
| Educating the next generation of ATMP professionals |
|
ADVANCE |
|
Prof. dr. Irena Mlinarič-Raščan |
|
ERASMUS+ |
|
1.11.2019 - 1.4.2022 |
| Open access Educational Materials on Naturally Occuring Molecules – sources, biological activity and use |
|
OEMONOM |
|
Prof. dr. Marija Sollner Dolenc |
|
ERASMUS+ |
|
1.9.2020 - 1. 8. 2023 |
| EATRIS-Plus – flagship in personalized medicine |
|
EATRIS Plus |
|
Prof. dr. Irena Mlinarič-Raščan |
|
H2020 |
|
1.1.2020 - 31.12.2023 |
| Open Research Biopharmaceutical Internships Support |
|
ORBIS |
|
Prof. dr. Rok Dreu |
|
H2020 |
|
1.10.2021 - 30.6.2023 |
| REMEDI4ALL |
|
REMEDI4ALL |
|
Prof. dr. Irena Mlinarič-Raščan
Prof. dr. Rok Dreu |
|
Horizon Europe |
|
2021-2027 |
| European Partnership for the Assessment of Risks from Chemicals (PARC) |
|
PARC |
|
Prof. dr. Marija Sollner Dolenc |
|
Horizon Europe |
|
2021-2027 |
| |
|
BREAKthrough |
|
Stanislav Gobec |
|
Horizon Europe |
|
2023-2026 |
| Evropska noč raziskovalcev - Humanistika, to si ti! letos nosi naslov »Človek živali in žival človeku« |
|
Evropska noč raziskovalcev |
|
Alenka Zvonar Pobirk |
|
Horizon Europe
|
|
30.9.2022 |